Dynamic ctDNA Assessment in Cervical and Anal Canal Tumors: Optimizing Follow-up and Clinical Outcomes
Conditions
- HPV-Related Carcinoma
- Uterine Cervical Cancer
- Anal Canal Cancer
- HPV-Related Anal Squamous Cell Carcinoma
- HPV-Related Cervical Carcinoma
Interventions
- DIAGNOSTIC_TEST: ctDNA test
- DRUG: Pembrolizumab
Sponsor
Instituto do Cancer do Estado de São Paulo
Collaborators